154 related articles for article (PubMed ID: 21533592)
21. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.
Toyama Y; Ushigome T; Watanabe K; Kitamura H; Onda S; Saito R; Yoshida S; Kawahara H; Yanagisawa S; Yanaga K
World J Surg Oncol; 2012 Jun; 10():129. PubMed ID: 22747970
[TBL] [Abstract][Full Text] [Related]
22. Recurrent giant cranial desmoid tumor in a 3-year-old boy with familial adenomatous polyposis requiring bifrontoparietal cranioplasty: case report.
Li L; Jensen JN; Szabo S; VanTuinen P; Lew SM
J Neurosurg Pediatr; 2016 Dec; 25(6):703-707. PubMed ID: 27635978
[TBL] [Abstract][Full Text] [Related]
23. Cetuximab or bevacizumab in metastatic colorectal cancer?
Sclafani F; Cunningham D
Lancet Oncol; 2014 Sep; 15(10):1040-1. PubMed ID: 25088941
[No Abstract] [Full Text] [Related]
24. FOLFOXIRI and bevacizumab in metastatic colorectal cancer.
Rahman A
Lancet Oncol; 2014 Dec; 15(13):e590. PubMed ID: 25499288
[No Abstract] [Full Text] [Related]
25. [Desmoid type fibromatosis, from radical excision to molecular extirpation].
Penel N; Orbach D
Bull Cancer; 2020 Mar; 107(3):344-345. PubMed ID: 32178793
[No Abstract] [Full Text] [Related]
26. [A Case of Familial Adenomatous Polyposis with a Desmoid Tumor Probably Communicating to the Intestinal Lumen That Was Successfully Treated with Non-Surgical Therapy].
Ito T; Chika N; Yamamoto A; Ogura T; Amano K; Ishiguro T; Fukuchi M; Kumagai Y; Ishibashi K; Eguchi H; Okazaki Y; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2316-2319. PubMed ID: 28133307
[TBL] [Abstract][Full Text] [Related]
27. CT appearances of desmoid tumours in familial adenomatous polyposis: further observations.
Brooks AP; Reznek RH; Nugent K; Farmer KC; Thomson JP; Phillips RK
Clin Radiol; 1994 Sep; 49(9):601-7. PubMed ID: 7955885
[TBL] [Abstract][Full Text] [Related]
28. MR appearances of desmoid tumors in familial adenomatous polyposis.
Healy JC; Reznek RH; Clark SK; Phillips RK; Armstrong P
AJR Am J Roentgenol; 1997 Aug; 169(2):465-72. PubMed ID: 9242755
[TBL] [Abstract][Full Text] [Related]
29. A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
Papadimitriou CA; Papakostas P; Karina M; Malettou L; Dimopoulos MA; Pentheroudakis G; Samantas E; Bamias A; Miliaras D; Basdanis G; Xiros N; Klouvas G; Bafaloukos D; Kafiri G; Papaspirou I; Pectasides D; Karanikiotis C; Economopoulos T; Efstratiou I; Korantzis I; Pisanidis N; Makatsoris T; Matsiakou F; Aravantinos G; Kalofonos HP; Fountzilas G
BMC Med; 2011 Jan; 9():10. PubMed ID: 21281463
[TBL] [Abstract][Full Text] [Related]
30. The use of high dose d,l-leucovorin in first-line bevacizumab+mFOLFIRI treatment of patients with metastatic colorectal cancer may enhance the antiangiogenic effect of bevacizumab.
Budai B; Nagy T; Láng I; Hitre E
Angiogenesis; 2013 Jan; 16(1):113-21. PubMed ID: 22956187
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta.
Yoon S; Schmassmann-Suhijar D; Zuber M; Konietzny P; Schmassmann A
Ann Oncol; 2006 Dec; 17(12):1851-2. PubMed ID: 16777923
[No Abstract] [Full Text] [Related]
32. Intra-abdominal desmoid tumors in familial adenomatous polyposis: How much do clinical and surgical variables interfere with their development?
Campos FG; Martinez CAR; Bustamante-Lopez LA; Mendonça RLDS; Kanno DT
Clinics (Sao Paulo); 2023; 78():100144. PubMed ID: 36476966
[TBL] [Abstract][Full Text] [Related]
33. Recurrent abdominal pain in a young man.
Matson MB; Hatrick AG; Howlett DC
Br J Radiol; 1998 Oct; 71(850):1105-6. PubMed ID: 10211076
[No Abstract] [Full Text] [Related]
34. Irinotecan-induced immune thrombocytopenia.
Mirtsching BC; George JN; Aster RH; Curtis BR
Am J Med Sci; 2014 Feb; 347(2):167-9. PubMed ID: 24472819
[No Abstract] [Full Text] [Related]
35. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis (Br J Surg 2006; 93; 1258-1264).
Rix TE
Br J Surg; 2007 Feb; 94(2):250-1. PubMed ID: 17256816
[No Abstract] [Full Text] [Related]
36. Desmoid tumors respond to chemotherapy: defying the dogma in oncology.
Patel SR; Benjamin RS
J Clin Oncol; 2006 Jan; 24(1):11-2. PubMed ID: 16330666
[No Abstract] [Full Text] [Related]
37. Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case.
Ezumi K; Yamamoto H; Takemasa I; Nomura M; Ikeda M; Sekimoto M; Monden M
Jpn J Clin Oncol; 2008 Mar; 38(3):222-6. PubMed ID: 18304951
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study).
Ducreux M; Adenis A; Pignon JP; François E; Chauffert B; Ichanté JL; Boucher E; Ychou M; Pierga JY; Montoto-Grillot C; Conroy T
Eur J Cancer; 2013 Apr; 49(6):1236-45. PubMed ID: 23352604
[TBL] [Abstract][Full Text] [Related]
39. Significance of incidental desmoids identified during surgery for familial adenomatous polyposis.
Hartley JE; Church JM; Gupta S; McGannon E; Fazio VW
Dis Colon Rectum; 2004 Mar; 47(3):334-8; discussion 339-40. PubMed ID: 14991495
[TBL] [Abstract][Full Text] [Related]
40. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
Loupakis F; Cremolini C; Masi G; Lonardi S; Zagonel V; Salvatore L; Cortesi E; Tomasello G; Ronzoni M; Spadi R; Zaniboni A; Tonini G; Buonadonna A; Amoroso D; Chiara S; Carlomagno C; Boni C; Allegrini G; Boni L; Falcone A
N Engl J Med; 2014 Oct; 371(17):1609-18. PubMed ID: 25337750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
